Sangamo Therapeutics, Inc.
SGMO
Price:
$2.39
Market Cap:
$498.67M
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucleases, which are proteins used in modifying DNA sequences by adding or knocking out specific genes; and ZFP transcription factors proteins used in increasing or decreasing gene expression. It develops SB-525, which is in Phase III AFFINE clinical trial for the treatment of hemophilia A; ST-920, a gene therapy, which is in Phase I/II STAAR clinical tria...[Read more]
Industry
Biotechnology
IPO Date
2000-04-06
Stock Exchange
NASDAQ
Ticker
SGMO
PE Ratio
[-3.37]
ROE
[-266.47%]
Current Ratio
[1.35]
Dividend Yield
[0%]
Enterprise Value
[487.19M]
Dividend History
The ROE as of December 2024 (TTM) for Sangamo Therapeutics, Inc. (SGMO) is -266.47%
According to Sangamo Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -266.47%. This represents a change of 274.58% compared to the average of -71.14% of the last 4 quarters.
Sangamo Therapeutics, Inc. (SGMO) Historical ROE (quarterly & annually)
How has SGMO ROE performed in the past?
The mean historical ROE of Sangamo Therapeutics, Inc. over the last ten years is -59.99%. The current -266.47% ROE has changed 344.22% with respect to the historical average. Over the past ten years (40 quarters), SGMO's ROE was at its highest in in the September 2024 quarter at 27.27%. The ROE was at its lowest in in the June 2024 quarter at -152.50%.
Average
-59.99%
Median
-26.70%
Minimum
-311.06%
Maximum
-12.78%
Sangamo Therapeutics, Inc. (SGMO) ROE by Quarter and Year
Discovering the peaks and valleys of Sangamo Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 377.18%
Maximum Annual ROE = -12.78%
Minimum Annual Increase = -44.80%
Minimum Annual ROE = -311.06%
| Year | ROE | Change |
|---|---|---|
| 2023 | -311.06% | 377.18% |
| 2022 | -65.19% | 37.23% |
| 2021 | -47.50% | 95.06% |
| 2020 | -24.35% | 39.00% |
| 2019 | -17.52% | -6.03% |
| 2018 | -18.64% | -35.80% |
| 2017 | -29.04% | -44.80% |
| 2016 | -52.61% | 148.75% |
| 2015 | -21.15% | 65.44% |
| 2014 | -12.78% | -41.56% |
Sangamo Therapeutics, Inc. (SGMO) Average ROE
How has SGMO ROE performed in the past?
The current ROE of Sangamo Therapeutics, Inc. (SGMO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-141.25%
5-year avg
-93.13%
10-year avg
-59.99%
Sangamo Therapeutics, Inc. (SGMO) ROE vs. Peers
How is SGMO’s ROE compared to its peers?
Sangamo Therapeutics, Inc.’s ROE is greater than Editas Medicine, Inc. (-80.13%), greater than Intellia Therapeutics, Inc. (-51.97%), greater than bluebird bio, Inc. (-322.46%), less than Alnylam Pharmaceuticals, Inc. (323.66%), less than ImmunoGen, Inc. (5.04%),
| Company | ROE | Market cap |
|---|---|---|
| -80.13% | $103.19M | |
| -51.97% | $1.23B | |
| -322.46% | $74.47M | |
| 323.66% | $31.25B | |
| 5.04% | $8.73B |
Build a custom stock screener for Sangamo Therapeutics, Inc. (SGMO) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sangamo Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Sangamo Therapeutics, Inc. (SGMO) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Sangamo Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Sangamo Therapeutics, Inc.'s ROE?
How is the ROE calculated for Sangamo Therapeutics, Inc. (SGMO)?
What is the highest ROE for Sangamo Therapeutics, Inc. (SGMO)?
What is the 3-year average ROE for Sangamo Therapeutics, Inc. (SGMO)?
What is the 5-year average ROE for Sangamo Therapeutics, Inc. (SGMO)?
How does the current ROE for Sangamo Therapeutics, Inc. (SGMO) compare to its historical average?